PAPER Strijkert F, Scheenen ME, Huitema RB, van den Berg E, van Munster BC, Spikman JM
SEARCH RESULTS
1791 RESULTS
PAPER Davidowitz EJ, Lopez P, Patel D, Jimenez H, Wolin A, Eun J, Adrien L, Koppel J, Morgan D, Davies P, Moe JG
Therapeutic Treatment With OLX-07010 Inhibited Tau Aggregation and Ameliorated Motor Deficits in an Aged Mouse Model of Tauopathy.
J Neurochem. 2025 Mar;169(3):e70025. PubMed.PAPER Liu H, Zhang X, Liu Q
A review of AI-based radiogenomics in neurodegenerative disease.
Front Big Data. 2025;8:1515341. Epub 2025 Feb 20 PubMed.PAPER Olofsson HE, Englund E
Increased frontocortical microvascular raspberry density in frontotemporal lobar degeneration compared to Lewy body disease and control cases: a neuropathological study.
Free Neuropathol. 2025 Jan;6:7. Epub 2025 Mar 4 PubMed.PAPER Steeves A, Faig K, McGibbon C, Sexton A, Jarrett P
Assessing Cognition Remotely: Expanding the Reach of Cognitive Testing for Older Adults at Risk for Dementia in a Randomized Controlled Trial.
Can Geriatr J. 2025 Mar;28(1):87-90. Epub 2025 Mar 1 PubMed.PAPER Liu JJ, Wei F, Wang YD, Liu J, Xu BL, Ma SC, Yang JB
Ginseng and Polygonum multiflorum formula protects brain function in Alzheimer's disease.
Front Pharmacol. 2025;16:1461177. Epub 2025 Feb 20 PubMed.PAPER Jiang R, Zheng X, Sun J, Chen L, Xu G, Zhang R
Classification for Alzheimer's disease and frontotemporal dementia via resting-state electroencephalography-based coherence and convolutional neural network.
Cogn Neurodyn. 2025 Dec;19(1):46. Epub 2025 Mar 4 PubMed.PAPER Bobbins A, Davies M, Lynn E, Roy D, Yeomans A, Shakir SA
Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective.
Br J Clin Pharmacol. 2025 Mar 6; Epub 2025 Mar 6 PubMed.PAPER Gonzalez MC, Oftedal L, Lange J, Tovar-Rios DA, Tysnes OB, Paquet C, Marquié M, Boada M, Alcolea D, Rejdak K, Papuc E, Hort J, Falup-Pecurariu C, Aarsland D, Alves G, Maple-Grødem J
Relationship of cognitive decline with glucocerebrosidase activity and amyloid-beta 42 in DLB and PD.
Ann Clin Transl Neurol. 2025 Mar 6; Epub 2025 Mar 6 PubMed.PAPER Ma J, Tian Y, Du C, Zhu Y, Huang W, Ding C, Wei P, Yi X, Lin Z, Fang W
Cerium-doped Prussian blue biomimetic nanozyme as an amplified pyroptosis inhibitor mitigate Aβ oligomer-induced neurotoxicity in Alzheimer's disease.
J Nanobiotechnology. 2025 Mar 6;23(1):181. PubMed.PAPER Carroll E, Scaber J, Huber KV, Brennan PE, Thompson AG, Turner MR, Talbot K
Drug repurposing in amyotrophic lateral sclerosis (ALS).
Expert Opin Drug Discov. 2025 Mar 7;:1-18. Epub 2025 Mar 7 PubMed.PAPER Galeano Niño JL, Wu H, LaCourse KD, Kempchinsky AG, Baryiames A, Barber B, Futran N, Houlton J, Sather C, Sicinska E, Taylor A, Minot SS, Johnston CD, Bullman S
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer.
Nature. 2022 Nov;611(7937):810-817. Epub 2022 Nov 16 PubMed.PAPER Tan CC, Ko KK, Chen H, Liu J, Loh M, SG10K_Health Consortium, Chia M, Nagarajan N
No evidence for a common blood microbiome based on a population study of 9,770 healthy humans.
Nat Microbiol. 2023 May;8(5):973-985. Epub 2023 Mar 30 PubMed.Rupal Mehta on Do Specialized Glycoproteins Prop Up Blood-Brain Barrier?
COMMENT It is remarkable how much remains unknown about the normal structure of blood vessels in the mammalian brain, and about how cerebral vessel structure changes with age. The anatomy has been understudied, and routine staining methods and transmission electr
In Amyloidosis, EphA4 Goads Astrocytes to Massacre Synapses
RESEARCH NEWS 2025-03-07 Research News Astrocytes are notoriously two-faced—calmly coddling neurons one minute, then ruthlessly consuming their synapses the next. Why these dramatic mood swings? Blame the EphA4 receptor, according to a study published February 18 in Proceedings o
Current Filters
- Date Range : Feb 2025 to Mar 2025 x